CASI Pharmaceuticals, Inc (DE)
CASIDelisted- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000895051
CASI Pharmaceuticals, Inc (DE) was delisted in 2023; its insiders filed their last Form 4 on Sep 9, 2022; 23 institutions reported holding it in 13F filings for Q4 2022, worth $3.31M in total; no superinvestor held it.
Q1 2022 vs. Q4 2021
How the institutions holding CASI Pharmaceuticals, Inc (DE) changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Of which not filed for Q1 2022 | Q1 2022 | Change |
|---|---|---|---|---|
| Holders | 51 | 1 | 45 | −5 |
| Shares | 28.0M | 17.5K | 23.3M | −4.62M (−16.5%) |
| Value | $22.4M | $14.0K | $18.9M | −$3.46M (−15.5%) |
1 institution that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (5)
Institutions that held CASI Pharmaceuticals, Inc (DE) at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citigroup Inc | 73,117 | $59.0K | 0.00% |
| Bailard, Inc. | 25,100 | $20.0K | 0.00% |
| Fragasso Group Inc. | 16,500 | $13.0K | 0.00% |
| Manatuck Hill Partners, LLC | 15,090 | $12.0K | 0.00% |
| Joseph P. Lucia & Associates, LLC | 1 | $0 | 0.00% |
Sold out (10)
Institutions that held CASI Pharmaceuticals, Inc (DE) at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Jacobs Levy Equity Management, Inc | 1,677,146 | $1.34M |
| Marshall Wace, LLP | 300,508 | $241.0K |
| Anson Funds Management LP | 267,507 | $214.0K |
| Two Sigma Securities, LLC | 88,667 | $71.0K |
| Two Sigma Advisers, LP | 83,200 | $67.0K |
| Two Sigma Investments, LP | 63,400 | $51.0K |
| Atom Investors LP | 33,891 | $27.0K |
| Connor, Clark & Lunn Investment Management Ltd. | 27,606 | $22.0K |
| Ground Swell Capital, LLC | 18,638 | $15.0K |
| UBS Group AG | 16,983 | $14.0K |
Not filed for Q1 2022 yet (1)
Institutions that held CASI Pharmaceuticals, Inc (DE) at the end of Q4 2021 and haven't filed a 13F for Q1 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Mosaic Family Wealth, LLC | 17,500 | $14.0K |